|
G |
Chrna1 |
cholinergic receptor nicotinic alpha 1 subunit |
multiple interactions |
EXP |
epibatidine binds to and results in increased activity of [CHRNA1 protein binds to CHRNB2 protein]; LYNX1 protein promotes the reaction [epibatidine binds to and results in increased activity of [CHRNA1 protein binds to CHRNB2 protein]]; LYPD1 protein promotes the reaction [epibatidine binds to and results in increased activity of [CHRNA1 protein binds to CHRNB2 protein]] |
CTD |
PMID:19619141 |
|
NCBI chr 3:58,454,763...58,469,832
Ensembl chr 3:58,454,744...58,469,840
|
|
G |
Chrna2 |
cholinergic receptor nicotinic alpha 2 subunit |
multiple interactions affects binding |
EXP ISO |
epibatidine binds to and results in increased activity of [CHRNA2 protein binds to CHRNB2 protein]; sazetidine-A analog inhibits the reaction [epibatidine binds to and results in increased activity of [CHRNA2 protein binds to CHRNB2 protein]] [CHRNB4 protein binds to CHRNA2 protein] which binds to epibatidine Epibatidine binds to Chrna2 protein epibatidine binds to Chrnb4 protein in the retina |
CTD RGD |
PMID:9454827 PMID:21905669 PMID:15016836 PMID:16129735 |
RGD:2303194, RGD:2303195 |
NCBI chr15:40,342,317...40,358,601
Ensembl chr15:40,342,317...40,358,601
|
|
G |
Chrna3 |
cholinergic receptor nicotinic alpha 3 subunit |
affects binding multiple interactions |
ISO EXP |
[CHRNB4 protein binds to CHRNA3 protein] which binds to epibatidine 2-(1'-methyl-2'-pyrrolidinyl)-7-hydroxy-1,4-benzodioxane inhibits the reaction [epibatidine binds to [CHRNA3 protein binds to CHRNB4 protein]]; epibatidine binds to and results in increased activity of [CHRNA3 protein binds to CHRNB4 protein] epibatidine binds to CHRNA3 protein Tretinoin promotes the reaction [epibatidine binds to CHRNA3 protein] [CHRNA3 protein binds to CHRNB4 protein] which binds to epibatidine; epibatidine binds to [CHRNA3 protein binds to CHRNB4 protein] epibatidine analog binds to and results in increased activity of [CHRNA3 protein binds to CHRNB4 protein] Epibatidine binds to Chrna3 protein |
CTD RGD |
PMID:9454827 PMID:9687574 PMID:15615518 PMID:17203487 PMID:21942635 PMID:22060139 PMID:15016836 PMID:16129735 More...
|
RGD:2303194, RGD:2303195 |
NCBI chr 8:55,401,668...55,415,165
Ensembl chr 8:55,401,702...55,415,165
|
|
G |
Chrna4 |
cholinergic receptor nicotinic alpha 4 subunit |
multiple interactions affects binding |
ISO EXP |
Acetylcholine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Acetylthiocholine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Alcuronium inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Carbachol inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Choline inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; cytisine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; decamethonium inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Dihydro-beta-Erythroidine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Dimethylphenylpiperazinium Iodide inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; epibatidine binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; epibatidine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; Hexamethonium inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Lobeline inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; methyllycaconitine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Nicotine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Pancuronium inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Physostigmine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; subecholine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Succinylcholine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Tubocurarine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Vecuronium Bromide inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]] [CHRNB4 protein binds to CHRNA4 protein] which binds to epibatidine; epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein] Tretinoin promotes the reaction [epibatidine binds to CHRNA4 protein] 2-(1'-methyl-2'-pyrrolidinyl)-7-hydroxy-1,4-benzodioxane inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; epibatidine binds to [CHRNA4 protein co-treated with CHRNB2 protein]; epibatidine binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; sazetidine-A analog inhibits the reaction [epibatidine binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]] Epibatidine binds to Chrna4 protein epibatidine binds to Chrnb4 protein in the rat retina |
CTD RGD |
PMID:9454827 PMID:10728888 PMID:11124396 PMID:14645658 PMID:15615518 PMID:17203487 PMID:21905669 PMID:21942635 PMID:22060139 PMID:15016836 PMID:16129735 More...
|
RGD:2303194, RGD:2303195 |
NCBI chr 3:168,136,246...168,157,839
Ensembl chr 3:168,136,266...168,156,957
|
|
G |
Chrna6 |
cholinergic receptor nicotinic alpha 6 subunit |
affects binding |
EXP |
epibatidine and alpha-Conotoxin MII bind to Chrna6 protein |
RGD |
PMID:22550286 |
RGD:8549526 |
NCBI chr16:64,697,741...64,704,441
Ensembl chr16:64,697,741...64,704,441
|
|
G |
Chrna7 |
cholinergic receptor nicotinic alpha 7 subunit |
multiple interactions affects binding affects activity |
ISO EXP |
1-(5-chloro-2,4-dimethoxyphenyl)-3-(5-methylisoxazol-3-yl)urea promotes the reaction [epibatidine affects the activity of CHRNA7 protein]; Bungarotoxins inhibits the reaction [epibatidine binds to CHRNA7 protein]; Carbachol inhibits the reaction [epibatidine binds to CHRNA7 protein]; methyllycaconitine inhibits the reaction [epibatidine binds to CHRNA7 protein]; PNU-282987 inhibits the reaction [epibatidine binds to CHRNA7 protein]; SAD-128 analog inhibits the reaction [epibatidine binds to CHRNA7 protein] epibatidine inhibits the reaction [iodo-alpha-bungarotoxin binds to CHRNA7 protein] |
CTD |
PMID:19448648 PMID:21703337 PMID:29248576 |
|
NCBI chr 1:116,711,559...116,837,269
Ensembl chr 1:116,714,711...116,837,240
|
|
G |
Chrnb2 |
cholinergic receptor nicotinic beta 2 subunit |
multiple interactions affects binding |
ISO EXP |
Acetylcholine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Acetylthiocholine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Alcuronium inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Carbachol inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Choline inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; cytisine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; decamethonium inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Dihydro-beta-Erythroidine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Dimethylphenylpiperazinium Iodide inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; epibatidine binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; epibatidine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; Hexamethonium inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Lobeline inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; methyllycaconitine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Nicotine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Pancuronium inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Physostigmine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; subecholine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Succinylcholine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Tubocurarine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Vecuronium Bromide inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]] 2-(1'-methyl-2'-pyrrolidinyl)-7-hydroxy-1,4-benzodioxane inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; epibatidine binds to [CHRNA4 protein co-treated with CHRNB2 protein]; epibatidine binds to [NACHRALPHA1 protein co-treated with CHRNB2 protein]; epibatidine binds to [NACHRALPHA2 protein co-treated with CHRNB2 protein]; epibatidine binds to [NACHRALPHA3 protein co-treated with CHRNB2 protein]; epibatidine binds to and results in increased activity of [CHRNA1 protein binds to CHRNB2 protein]; epibatidine binds to and results in increased activity of [CHRNA2 protein binds to CHRNB2 protein]; epibatidine binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; epibatidine results in increased activity of [NACHRALPHA1 protein co-treated with CHRNB2 protein]; LYNX1 protein promotes the reaction [epibatidine binds to and results in increased activity of [CHRNA1 protein binds to CHRNB2 protein]]; LYPD1 protein promotes the reaction [epibatidine binds to and results in increased activity of [CHRNA1 protein binds to CHRNB2 protein]]; sazetidine-A analog inhibits the reaction [epibatidine binds to and results in increased activity of [CHRNA2 protein binds to CHRNB2 protein]]; sazetidine-A analog inhibits the reaction [epibatidine binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]] Epibatidine binds to Chrnb2 protein epibatidine binds to Chrnb4 protein in the rat retina |
CTD RGD |
PMID:10728888 PMID:11124396 PMID:14645658 PMID:15615518 PMID:16291090 PMID:16981889 PMID:19619141 PMID:21905669 PMID:21942635 PMID:22060139 PMID:15016836 PMID:16129735 More...
|
RGD:2303194, RGD:2303195 |
NCBI chr 2:175,181,402...175,189,619
Ensembl chr 2:175,181,402...175,189,619
|
|
G |
Chrnb3 |
cholinergic receptor nicotinic beta 3 subunit |
affects binding |
EXP |
epibatidine binds to Chrnb4 protein in the rat retina |
RGD |
PMID:16129735 |
RGD:2303195 |
NCBI chr16:64,713,438...64,751,360
Ensembl chr16:64,714,169...64,751,360
|
|
G |
Chrnb4 |
cholinergic receptor nicotinic beta 4 subunit |
affects binding multiple interactions |
ISO EXP |
[CHRNB4 protein binds to CHRNA2 protein] which binds to epibatidine; [CHRNB4 protein binds to CHRNA3 protein] which binds to epibatidine; [CHRNB4 protein binds to CHRNA4 protein] which binds to epibatidine 2-(1'-methyl-2'-pyrrolidinyl)-7-hydroxy-1,4-benzodioxane inhibits the reaction [epibatidine binds to [CHRNA3 protein binds to CHRNB4 protein]]; epibatidine binds to and results in increased activity of [CHRNA3 protein binds to CHRNB4 protein] [CHRNA3 protein binds to CHRNB4 protein] which binds to epibatidine; epibatidine binds to [CHRNA3 protein binds to CHRNB4 protein] epibatidine analog binds to and results in increased activity of [CHRNA3 protein binds to CHRNB4 protein]; epibatidine binds to [NACHRALPHA1 protein co-treated with CHRNB4 protein]; epibatidine binds to [NACHRALPHA2 protein co-treated with CHRNB4 protein]; epibatidine binds to [NACHRALPHA3 protein co-treated with CHRNB4 protein] epibatidine binds to Chrnb4 protein in the retina |
CTD RGD |
PMID:9454827 PMID:9687574 PMID:10728888 PMID:15615518 PMID:21942635 PMID:22060139 PMID:16129735 More...
|
RGD:2303195 |
NCBI chr 8:55,417,583...55,437,027
Ensembl chr 8:55,418,313...55,437,027
|
|
G |
Chrnd |
cholinergic receptor nicotinic delta subunit |
multiple interactions |
EXP |
epibatidine binds to [NACHRALPHA3 protein co-treated with CHRND protein] |
CTD |
PMID:10728888 |
|
NCBI chr 9:87,862,417...87,870,833
Ensembl chr 9:87,862,407...87,870,833
|
|
G |
Chrng |
cholinergic receptor nicotinic gamma subunit |
multiple interactions |
EXP |
epibatidine binds to [NACHRALPHA3 protein co-treated with CHRNG protein] |
CTD |
PMID:10728888 |
|
NCBI chr 9:87,878,085...87,884,193
Ensembl chr 9:87,878,085...87,914,482
|
|
G |
Lynx1 |
Ly6/neurotoxin 1 |
multiple interactions |
EXP |
LYNX1 protein promotes the reaction [epibatidine binds to and results in increased activity of [CHRNA1 protein binds to CHRNB2 protein]] |
CTD |
PMID:19619141 |
|
NCBI chr 7:106,632,800...106,638,003
Ensembl chr 7:106,632,797...106,638,023
|
|
G |
Lypd1 |
Ly6/Plaur domain containing 1 |
multiple interactions |
EXP |
LYPD1 protein promotes the reaction [epibatidine binds to and results in increased activity of [CHRNA1 protein binds to CHRNB2 protein]] |
CTD |
PMID:19619141 |
|
NCBI chr13:37,326,459...37,368,515
Ensembl chr13:37,326,464...37,368,493
|
|
G |
Th |
tyrosine hydroxylase |
multiple interactions increases expression |
EXP |
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [epibatidine results in increased expression of TH mRNA]; 2',5'-dideoxyadenosine inhibits the reaction [epibatidine results in increased expression of TH mRNA] |
CTD |
PMID:15588622 |
|
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
|
|